Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance (Q37036297)
Jump to navigation
Jump to search
scientific article published on January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance |
scientific article published on January 2009 |
Statements
1 reference
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance (English)
1 reference
Peter Wipf
1 reference
Paul Dent
1 reference
Garth Powis
1 reference
Gordon B Mills
1 reference
Nathan T Ihle
1 reference
Robert Lemos
1 reference
Adly Yacoub
1 reference
Clint Mitchell
1 reference
Doris Siwak
1 reference
D Lynn Kirkpatrick
1 reference
1 reference
Identifiers
1 reference